Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial congenital mirror movements in which the cause of the disease is a mutation in the DCC gene.
Features include rarely findings: Mild intellectual disability and Agenesis of corpus callosum. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Mild intellectual disability |
DCC encodes DCC netrin 1 receptor (1,447 aa). Receptor for netrin required for axon guidance. Mediates axon attraction of neuronal growth cones in the developing nervous system upon ligand binding. Highest expression in Testis (6.5 TPM) and Brain Nucleus accumbens basal ganglia (2.8 TPM).
Mirror movements 1 is associated with mutations in the DCC gene on chromosome 18.
The DCC protein participates in DCC interaction with Netrin-1, DCC interacts with DIP13alpha, and DCC interaction with Ezrin pathways.
DCC is classified as a druggable target (Cell Surface and Kinase categories) with score 8.7.
The diagnosis of the disorder of congenital mirror movements (CMM) is established by clinical findings and, in some instances, molecular genetic testing.
CMM should be suspected in individuals with the following clinical features, imaging findings, and family history.
Clinical features
Source: GeneReviews — "Congenital Mirror Movements"
No approved treatments are currently available for mirror movements 1. The disease remains an area of unmet medical need.
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with congenital mirror movements (CMM), the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 3. Recommended Evaluations Following Initial Diagnosis in Individuals with Congenital Mirror Movements
No clinical trials have been registered for mirror movements 1.
13 publications have been identified in PubMed for mirror movements 1. Research spans Case Report / Case Series (31%), Basic Science / Preclinical (23%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 31% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 4:54 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Physiologic mild mirror movements may be seen in young children, but their persistence after age seven years is pathologic . The disorder of congenital mirror movements (CMM) is characterized by early-onset obvious mirror movements that persist throughout adulthood in individuals who typically have no other clinical disorders. In particular, the mirror movements are not usually associated with subsequent onset of additional neurologic manifestations. However, a subset of individuals with a heterozygous DCC pathogenic variant may have concomitant cognitive and/or neuropsychiatric issues, particularly if abnormalities of the corpus callosum are present (see and ). Mirror movements usually persist throughout life, without deterioration or improvement.
Source: GeneReviews — "Congenital Mirror Movements"
There are no clear and validated genotype-phenotype correlations for NTN1 or RAD51.
DCC
Pathogenic variants in the NTN1 binding interface may predispose to abnormalities in the development of the corpus callosum with or without CMM .
Males with truncating DCC pathogenic variants are more likely to present with CMM, while females with truncating DCC pathogenic variants are more likely to present with isolated ACC .
Source: GeneReviews — "Congenital Mirror Movements"
Penetrance is reduced regardless of whether the causative pathogenic variant is in DCC, NTN1, or RAD51. Penetrance for the CMM phenotype was estimated to be 42% in those with a heterozygous pathogenic DCC variant – the most frequent cause of CMM .
Source: GeneReviews — "Congenital Mirror Movements"
The differential diagnosis of congenital mirror movements (CMM) from mirror movements of other causes is mainly theoretic, as the findings in CMM are distinctive, isolated, and easily recognized. Physiologic mirror movements. The intensity of the mirror movements and their persistence after age seven years clearly differentiate pathologic from physiologic mirror movements. Mild physiologic mirror movements are frequent in normally developing young children. They usually disappear completely before age seven years and tend to recur gradually in old age . Syndromes with early-onset (congenital) mirror movements. Early-onset mirror movements are not always isolated; they may be a component of complex syndromes and congenital hemiplegia (the most common form of cerebral palsy) . Although the clinical characteristics of mirror movements have been less comprehensively investigated in these conditions, they resemble those of CMM. In practice, differential diagnosis of CMM is rarely an issue, as the associated findings are generally more significant. When the diagnosis is in doubt, brain and cervical MRI may be considered in children or adolescents with mirror movements. Table 2. Syndromes with Early-Onset Mirror Movements
Disorder | Gene(s) | MOI | Mirror Movements | Other Features |
|---|---|---|---|---|
ANOS1 Kallmann syndrome (KS) (See Isolated GnRH Deficiency.) | ANOS1 (KAL1) | XL | MM in persons w/KS is almost always linked to ANOS11 (ANOS1-KS accounts for ~5%-10% of isolated GnRH deficiency).; Prevalence of MM in KAL1-KS is 75%.1 | Hyposmia hypogonadotropic hypogonadism |
Joubert syndrome | ≥34 genes | ARXL2 | CMM is observed in some affected persons.3 | Hypoplasia of cerebellar vermis w/characteristic neuroradiologic molar tooth sign variable accompanying neurologic symptoms Klippel-Feil syndrome (KFS) (OMIM PS118100)4 |
MYO18B | ADAR | MM is present in minority of persons w/KFS (MM is likely linked to cervicomedullary neuroschisis). | Congenital fusion of cervical vertebrae | — |
Typical phenotype incl low posterior hairline, short neck, amplitude of neck movements Moebius syndrome (OMIM 157900) | Unknown | AD | MM is only occasionally reported.5 | Minimum criteria are congenital, non-progressive facial weakness in assoc w/limited abduction of 1 or both eyes. |
Nevoid basal cell carcinoma syndrome(Gorlin syndrome) | PTCH1(PTCH2)6SUFU | AD | MM reported in 1 person7 | Multiple basal cell carcinomas, jaw keratocysts, skeletal malformations |
Seckel syndrome(OMIM PS210600) | ATRCPAP (CENPJ)CEP152CEP63DNA2NINNSMCE2RBBP8TRAIP | AR | 1 reported person w/MM8 | Primary microcephaly, intellectual disability, often prenatal-onset growth restriction |
Wildervanck syndrome (OMIM 314600) | Unknown | XL? | 1 reported person w/MM9 | Klippel-Feil syndrome w/congenital perceptive deafness Duane syndrome10; Affected persons are almost exclusively female. AD =... |
Source: GeneReviews — "Congenital Mirror Movements"
Genetic testing for DCC is available. Testing is considered confirmatory for diagnosis.
System/Concern | Evaluation | Comment |
|---|
Neurologic | Evals to document difficulties w/ADL | Consider referral to rehab specialist. Consider head MRI imaging. |
counseling | By genetics professionals1 | To obtain a pedigree inform affected persons their families re nature, MOI, implications of CMM to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with Congenital Mirror Movements Manifestation/Concern | Treatment/Counseling | Considerations/Other |
Mirror movements | Adaptation of school environment | Incl allocation of extra time during exams limitation of amount of handwriting Avoid stigmatizing children adolescents. |
Neurocognitive deficits | Standard treatment | Consider referral to neurodevelopmental specialist. Complex bimanual movements or sustained/repetitive hand activity should be limited in order to reduce the occurrence of pain or discomfort in the upper limbs. |
Source: GeneReviews — "Congenital Mirror Movements"
Complex bimanual movements or sustained/repetitive hand activity should be limited in order to reduce the occurrence of pain or discomfort in the upper limbs.
Source: GeneReviews — "Congenital Mirror Movements"
Botulinum toxin injections have been successfully tried in one affected individual but are not usually proposed, as the risk of inducing a motor deficit generally exceeds the possible benefit. Noninvasive modulation of brain interhemispheric communication may be a possibility in the future . Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions.
Source: GeneReviews — "Congenital Mirror Movements"
View trials for mirror movements 1
3 |
23% |
Research summaries | 2 | 15% |
Clinical study results | 2 | 15% |
Other research | 1 | 8% |
Disease patterns and progression | 1 | 8% |
Harms FL (2026). [PMID: 41058181](https://pubmed.ncbi.nlm.nih.gov/41058181/). *HGG Adv*. [Case Report / Case Series]
Shah S (2026). [PMID: 41048055](https://pubmed.ncbi.nlm.nih.gov/41048055/). *Mov Disord Clin Pract*. [Case Report / Case Series]
Boening A (2026). [PMID: 41423382](https://pubmed.ncbi.nlm.nih.gov/41423382/). *J Physiother*. [Review / Meta-Analysis]
Noy L (2025). [PMID: 40050876](https://pubmed.ncbi.nlm.nih.gov/40050876/). *J Neuroeng Rehabil*. [Basic Science / Preclinical]
Yücel Şen AD (2025). [PMID: 40619166](https://pubmed.ncbi.nlm.nih.gov/40619166/). *J Neurogenet*. [Case Report / Case Series]
Antenucci P (2025). [PMID: 40367529](https://pubmed.ncbi.nlm.nih.gov/40367529/). *J Clin Neurosci*. [Clinical Trial Publication]
van Zuijlen MJP (2025). [PMID: 40354085](https://pubmed.ncbi.nlm.nih.gov/40354085/). *J Vis*. [Other]
Ouattas A (2025). [PMID: 40773481](https://pubmed.ncbi.nlm.nih.gov/40773481/). *PLoS One*. [Epidemiology / Natural History]
Cao GH (2025). [PMID: 41239616](https://pubmed.ncbi.nlm.nih.gov/41239616/). *Medicine (Baltimore)*. [Case Report / Case Series]
Xu J (2024). [PMID: 38948135](https://pubmed.ncbi.nlm.nih.gov/38948135/). *Front Neurol*. [Review / Meta-Analysis]